AICAR is a synthetic analogue of AMP, a molecule involved in cellular energy sensing. Inside cells it is converted to ZMP, which can activate the energy-sensing enzyme AMPK. Research discussed here examines metabolic regulation, endurance, insulin resistance and responses to heart injury, largely in preclinical models.
What Is AICAR?
AICAR (5-aminoimidazole-4-carboxamide-1-β-ribofuranoside) is a synthetic analog of AMP that enters cells and is phosphorylated to ZMP — a compound that mimics the AMP/ATP ratio increase associated with energy depletion. This activates AMPK as if energy reserves were exhausted, triggering the same metabolic adaptations that exercise induces.
Quick Reference
Member reference tables summarize the compound's research parameters.
AMPK is the cell's master energy regulator. When activated — by exercise, caloric restriction, or AICAR — it simultaneously increases fatty acid oxidation, stimulates glucose uptake via GLUT4 translocation, inhibits energy-consuming anabolic processes, and promotes mitochondrial biogenesis via PGC-1α. These are collectively the metabolic adaptations associated with endurance training.
Exercise Mimicry Research
Landmark research demonstrated that AICAR administration in sedentary mice increased running endurance by 44% and upregulated a gene expression profile in skeletal muscle nearly identical to that of trained animals — without any exercise. This finding generated enormous research interest in AICAR as a tool for studying exercise biology and as a potential therapeutic for conditions where exercise is contraindicated.
Metabolic Disease Applications
AICAR has been studied extensively in models of type 2 diabetes, obesity, non-alcoholic fatty liver disease, and cardiac ischemia. It reliably improves insulin sensitivity, reduces hepatic fat accumulation, and protects cardiac tissue from ischemia-reperfusion injury in preclinical models.
Research Indications
AMPK Activation and Metabolic Reprogramming
Strong Preclinical
AICAR's defining action is AMPK activation via ZMP accumulation. AMPK is the cell's master energy sensor — when activated, it switches metabolism from anabolic to catabolic mode: fatty acid oxidation increases, glucose uptake is enhanced, and protein/lipid synthesis is suppressed. AICAR is a primary research tool for probing exercise-induced metabolic pathways independent of mechanical stimulus.
Endurance Performance and Exercise Mimicry
Strong Preclinical
Narkar et al. (2008) demonstrated that AICAR alone — without any training — increased running endurance of sedentary mice by 44% over 4 weeks via mitochondrial biogenesis and oxidative gene expression. This established AICAR as the prototypical exercise-mimetic research compound. WADA prohibited AICAR in 2011, acknowledging performance concerns before human data existed.
Insulin Resistance and Metabolic Syndrome
Metabolic Research
AICAR activates GLUT4 translocation to the cell surface in skeletal muscle via AMPK, independent of insulin signaling. This AMPK-driven glucose uptake pathway is intact even in insulin-resistant cells, making AICAR a tool for studying non-insulin-dependent glucose management in type 2 diabetes and metabolic syndrome models.
Cardioprotection / Ischemia-Reperfusion Injury
Emerging Research
AICAR and its precursor acadesine have been investigated in cardiac surgery and ischemic heart disease models. AMPK activation provides myocardial protection during ischemic stress by shifting substrate use, reducing mitochondrial permeability transition, and attenuating cell death pathways. Phase II cardiac trials for acadesine showed mixed results in CABG patients.
Anti-Inflammatory and Immunomodulatory Research
Emerging Research
AMPK activation by AICAR inhibits NF-κB and MAPK inflammatory signaling. Preclinical studies show reduced inflammatory cytokine production, attenuation of autoimmune disease severity in rodent models, and suppression of innate immune activation. These effects are secondary to the primary metabolic mechanism but have generated independent research interest.
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
AICAR (MW 338.2 Da, also known as acadesine or AICA ribonucleoside) is a well-characterized nucleoside analog. Purity certificates should specify AICAR (acadesine), not the deaminated analog AICA or the free base AICA without the ribose moiety. Reputable suppliers provide HPLC chromatograms.
Verified Marker
Lyophilized Powder with Cold-Chain Shipping
AICAR is a nucleoside analog and is degraded by heat and moisture over time. Products that arrive at room temperature in powder form without cold-chain packaging (or explicit evidence of stability at room temp) carry a real degradation risk. Reconstituted solutions should be used promptly or stored at 2–8°C.
Quality Concern
Confusion with AICA vs AICAR
AICA (5-aminoimidazole-4-carboxamide) is the free base without the ribose group. It does NOT activate AMPK — that requires the riboside (AICAR). Suppliers mislabeling or confusing the two compounds represent a quality and safety issue. The listed research text specifies confirming the product is 'acadesine' or 'AICA ribonucleoside' explicitly.
Quality Concern
No Independent Third-Party Testing
Given hypoglycemia risk and the absence of human safety data, sourcing AICAR without independent third-party verification is an elevated risk compared to other research compounds. Identity and purity verification via independent lab is essential.